Your Messages Inbox
Your Article Summary
See Latest ArticlesLilly Gets Green Light to Sell Prasugrel in Europe
PharmExec, 02/26/09
Eli Lilly and Tokyo-based Daiichi Sankyo announced Monday that their jointly developed blood thinner, Efient , was approved in Europe for patients with acute coronary syndrome undergoing percutaneous coronary intervention. Efient will be launching in some European countries as early as April, with more launches scheduled throughout Europe for the rest of the year.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Article Search
Sponsor